AGCO launched the TTX brand, consolidating its precision technology offerings and aiming to achieve $2 billion in Precision Ag sales by 2029. Over 1,000 PTx dealers are now active, with plans to grow ...
Despite a challenging quarter with a 24% sales drop, AGCO Corp (AGCO) showcases resilience through strong operating margins ...
Fendt, Massey Ferguson and PTx to showcase Farmer-Focused innovations at February trade shows in California and Kentucky.
In the aftermath of costly U.S. frustrations in Vietnam, Iraq and Afghanistan, advocating foreign policy "realism" is often ...
Good day, and welcome to the AGCO fourth quarter 2024 earnings call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Greg Peterson, ...
22h
Interesting Engineering on MSNA paradigm shift? The view from China on DeepSeek and the global AI raceDeepSeek has shown that China can, in part, sidestep US restrictions on advanced chips by leveraging algorithmic innovations.
Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the New England Journal of Medicine (NEJM) published results of the 204-patient, global, ...
Wells Fargo (NYSE:WFC) initiated coverage on Merus N.V. (NASDAQ:MRUS), currently trading at $41.54 with a market capitalization of $2.84 billion, with an Overweight rating and a price target of $91.00 ...
1d
Tech Xplore on MSNQ&A: How DeepSeek is changing the AI landscapeOn Monday January 27, a little known Chinese start-up called DeepSeek sent shockwaves and panic through Silicon Valley and ...
Despite a tense geopolitical environment, Vestas Wind officials are moving forward into 2025 expecting continued profitability amid the growing need for electricity with AI and cloud computing.
Financial writer discusses how the recent stock dip in Nvidia Corporation is a buying opportunity ahead of Q4 earnings. Click ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results